Does this data, in the absence of any tie to cancer, underscore the safety of other *drug* products they have developed and are developing?
Can they add this safety data to their data under review by the EMA and FDA? (eg No tie to cancer??)
Good questions for the CC.
Sentiment: Strong Buy